Histamine releasing activity (HRA) produced by leukocytes co-cultured with tumor cells.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 2442099)

Published in Immunol Invest on April 01, 1987

Authors

M P Langford, M A Lett-Brown, G J Stanton, J A Grant

Articles by these authors

Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes. Infect Immun (1978) 3.01

The interferons. Mechanisms of action and clinical applications. JAMA (1991) 2.68

Hereditary angioedema: its diagnostic and management perspectives. Am J Med (1990) 2.50

A habitable fluvio-lacustrine environment at Yellowknife Bay, Gale crater, Mars. Science (2013) 2.50

Spina bifida outcome: a 25-year prospective. Pediatr Neurosurg (2001) 2.38

Introducing a drug formulary to general practice--effects on practice prescribing costs. J R Coll Gen Pract (1987) 2.24

Novel alpha2-adrenoreceptors primarily responsible for inducing human platelet aggregation. Nature (1979) 2.17

Relative ability of mitogens to stimulate production of interferon by lymphoid cells and to induce suppression of the in vitro immune response. Proc Soc Exp Biol Med (1977) 2.07

Quantitative evaluation of a screening program. Am J Public Health (1974) 2.00

Large-scale production and physicochemical characterization of human immune interferon. Infect Immun (1979) 1.99

Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon. Cell Immunol (1980) 1.85

Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses. J Exp Med (1982) 1.81

Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients. Am J Respir Crit Care Med (1996) 1.75

Contribution of general practitioner hospitals in Scotland. Br Med J (Clin Res Ed) (1984) 1.74

Histamine-releasing activity (HRA). I. Production by mitogen- or antigen-stimulated human mononuclear cells. J Immunol (1979) 1.72

A closer look at water-related geologic activity on Mars. Science (2007) 1.71

Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils. J Clin Invest (1992) 1.66

Volatile and organic compositions of sedimentary rocks in Yellowknife Bay, Gale crater, Mars. Science (2013) 1.65

Acute hemorrhagic conjunctivitis. Am Fam Physician (1992) 1.62

Virus plaque-reduction assay for interferon: microplaque and regular macroplaque reduction assays. Methods Enzymol (1981) 1.62

Community hospitals--time to come off the fence. J R Coll Gen Pract (1989) 1.57

Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2. Virology (1990) 1.52

Hydrated silicate minerals on Mars observed by the Mars Reconnaissance Orbiter CRISM instrument. Nature (2008) 1.52

Refractory cholinergic urticaria successfully treated with ketotifen. J Allergy Clin Immunol (1989) 1.52

Nonsensitized lymphocytes produce leukocyte interferon when cultured with foreign cells. Cell Immunol (1979) 1.51

Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood (2000) 1.51

RANTES is a chemotactic and activating factor for human eosinophils. J Immunol (1993) 1.49

Genetic variation among dengue 2 viruses of different geographic origin. Virology (1983) 1.48

Interleukin 2 enhances natural killer cell activity through induction of gamma interferon. Infect Immun (1983) 1.45

Respiratory viruses induce production of histamine-releasing factor by mononuclear leukocytes: a possible role in the mechanism of virus-induced asthma. J Infect Dis (1991) 1.43

Monstrous, crablike hypertrophy of the cerebellar vermis and its relationship with Lhermitte-Duclos disease. Case report. J Neurosurg (1996) 1.39

Partial nucleotide sequence of St. Louis encephalitis virus RNA: structural proteins, NS1, ns2a, and ns2b. Virology (1987) 1.34

Comparative effect of recombinant IL-1, -2, -3, -4, and -6, IFN-gamma, granulocyte-macrophage-colony-stimulating factor, tumor necrosis factor-alpha, and histamine-releasing factors on the secretion of histamine from basophils. J Immunol (1989) 1.30

Macrophage inflammatory protein-1 alpha activates basophils and mast cells. J Exp Med (1992) 1.27

Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains. J Virol (1984) 1.26

The intrinsic helix-forming tendency of L-alanine. Proc Natl Acad Sci U S A (1992) 1.26

Role of interferon in streptococcal infection in the mouse. Microb Pathog (1986) 1.24

Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma). J Immunol (1981) 1.23

Vesicular stomatitis virus plaque production in monolayer cultures with liquid overlay medium: description and adaptation to a one-day, human interferon-plaque. J Clin Microbiol (1976) 1.22

Complement-mediated release of histamine from human leukocytes. J Immunol (1975) 1.20

Personal accounts of the role of God in health and illness among older rural African American and White residents. J Cross Cult Gerontol (2000) 1.17

Histamine-releasing activity (HRA). II. Interaction with basophils and physicochemical characterization. J Immunol (1979) 1.15

Elemental geochemistry of sedimentary rocks at Yellowknife Bay, Gale crater, Mars. Science (2013) 1.14

Genetic variation and microevolution of dengue 2 virus in Southeast Asia. Virology (1989) 1.13

Antibody and interferon act synergistically to inhibit enterovirus, adenovirus, and herpes simplex virus infection. Infect Immun (1983) 1.13

Effect of interferon, elevated temperature, and cell type on replication of acute hemorrhagic conjunctivitis viruses. Infect Immun (1977) 1.13

Virus yield-reduction assay for interferon by titration of Sindbis virus hemagglutinin. Methods Enzymol (1981) 1.12

Neutralization of native human gamma interferon (HuIFN gamma) by antibodies to a synthetic peptide encoded by the 5' end of HuIFN gamma cDNA. J Immunol (1982) 1.12

Spinal lipomas in children: outcome of 270 procedures. Pediatr Neurosurg (1997) 1.11

Interaction of selective alpha-adrenoceptor agonists and antagonists with human and rabbit blood platelets. Br J Pharmacol (1980) 1.10

Simultaneous generation of tuberculin-type and cutaneous basophilic hypersensitivity at separate sites in the guinea pig. Int Arch Allergy Appl Immunol (1979) 1.09

Enhanced detection of Western equine encephalitis virus plaque variants in crowded cultures and plaque progeny--potential use in genetic studies. Appl Microbiol (1974) 1.08

Expression of high-affinity IgE receptors (Fc epsilon RI) on peripheral blood basophils, monocytes, and eosinophils in atopic and nonatopic subjects: relationship to total serum IgE concentrations. J Allergy Clin Immunol (1997) 1.08

Mindfulness meditation-related pain relief: evidence for unique brain mechanisms in the regulation of pain. Neurosci Lett (2012) 1.08

Geographic classification of dengue-2 virus strains by antigen signature analysis. Virology (1986) 1.08

'Idiopathic' nephrotic syndrome is not always idiopathic. Tex Med (1990) 1.07

Complement-mediated release of histamine from human basophils. II. Biochemical characterization of the reaction. J Immunol (1976) 1.05

Potentiation of lymphocyte natural killing by mixtures of alpha or beta interferon with recombinant gamma interferon. Infect Immun (1983) 1.04

Efficient transfer of interferon-induced virus resistance between human cells. J Gen Virol (1978) 1.04

Modulation of immune responses by anabolic androgenic steroids. Int J Immunopharmacol (1995) 1.03

In situ radiometric and exposure age dating of the martian surface. Science (2013) 1.03

The Opportunity Rover's Athena science investigation at Meridiani Planum, Mars. Science (2004) 1.03

Human B lymphocytes produce leukocyte interferon after interaction with foreign cells. Infect Immun (1981) 1.02

High-affinity IgE receptor (FcepsilonRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Respir Crit Care Med (1996) 1.02

Partial amino acid sequences of chicken and turkey immunoglobulin light chains. Homology with mammalian lambda chains. Biochemistry (1971) 0.99

Cellular origin of histamine-releasing factor produced by peripheral blood mononuclear cells. J Immunol (1989) 0.98

A comparison of New World alphaviruses in the western equine encephalomyelitis complex by immunochemical and oligonucleotide fingerprint techniques. J Gen Virol (1980) 0.98

Virus and bacteria enhance histamine production in middle ear fluids of children with acute otitis media. J Infect Dis (1994) 0.97

Early-appearing antiviral activity in human tears during a case of picornavirus epidemic conjunctivitis. J Infect Dis (1979) 0.97

Effect of specific antibodies on chronic echovirus type 5 encephalitis in a patient with hypogammaglobulinemia. J Infect Dis (1979) 0.97

Chemotactic responses of normal human basophils to C5a and to lymphocyte-derived chemotactic factor. J Immunol (1976) 0.97

Release of slow reacting substance of anaphylaxis from human leukocytes. J Immunol (1974) 0.97

Human fibroblast interferon in tears of patients with picornavirus epidemic conjunctivitis. Infect Immun (1980) 0.97

Positive interaction between agonists in the aggregation response of human blood platelets: interation between ADP, adrenaline and vasopressin. Br J Haematol (1980) 0.95

Histamine-induced inhibition of normal human basophil chemotaxis to C5a. J Immunol (1977) 0.94

Nondetectable levels of interferon gamma is a critical host defense during the first day of herpes simplex virus infection. Microb Pathog (1987) 0.93

The Spirit Rover's Athena science investigation at Gusev Crater, Mars. Science (2004) 0.92